Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Solid Tumor Study for Long Term Treatment of Cancer Patients Who Have Participated in BMS Parent Studies Investigating Adagrasib (BMS-986503)

NCT07415031 is registered in ClinicalTrials.gov with Mirati Therapeutics Inc. as lead sponsor.

NCT NCT07415031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07415031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Solid Tumor Study for Long Term Treatment of Cancer Patients Who Have Participated in BMS Parent Studies Investigating Adagrasib (BMS-986503)
Lead sponsor
Mirati Therapeutics Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
May 6, 2026
Completion date
February 16, 2028
Enrollment
170 (estimated)
Sites
102

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors